Abstract-The activity of estrogen-receptor (ER) agonists in sediments collected from the United Kingdom (UK) estuaries was assessed using the in vitro recombinant yeast estrogen screen (YES assay). The YES assay was successfully used to determine the in vitro ER agonist potency of pore waters and solvent extracts of sediments collected from UK estuaries. Estrogen-receptor agonists were detected in 66% of the pore water samples and in 91% of the sediment solvent extracts tested. The pore waters tested had ER agonist potencies from less than 2 to 68 ng 17␤-estradiol (E 2 ) L Ϫ1 , whereas sediment extracts had potencies from less than 0.2 to 13 g E 2 kg
INTRODUCTION
Concern has increased in recent years regarding the range of effects exerted by xenobiotics in the environment [1] . One area of research that has received particular attention is the effect of contaminants on the endocrine system of exposed species. The endocrine system regulates hormonal processes in the body. Some chemicals appear to be able to mimic hormones and, therefore, to disrupt homeostasis. The most widely studied hormone function is that of the estrogen receptor (ER). Several substances are known to mimic natural estrogens, such as polychlorinated biphenyls, alkylphenols, phthalate esters, and the contraceptive pill component 17␣-ethynylestradiol [2] [3] [4] [5] [6] . Natural steroid estrogens have also been identified in environmental systems [3, 6] . These compounds bind to the ER, regulating the activity of estrogen-responsive genes. Effects consistent with exposure to estrogenic substances have been observed in wild fish populations. In the United Kingdom, this phenomenon has been predominantly observed as the occurrence of elevated plasma vitellogenin levels and feminized reproductive organs in certain male freshwater and estuarine species (for review, see [7] ).
The Oslo and Paris (OSPAR) Commission, which regulates pollution of the North Sea, has included endocrine disruption as a criterion for defining hazardous substances as being of concern and the discharges of which to the marine environment are to be reduced to near zero by 2020. The ER agonists in sewage treatment works effluents and estuarine surface waters have been characterized as a mixture of natural steroids (e.g., 17␤-estradiol [E 2 ]) and xenoestrogens (e.g., nonylphenol and phthalate esters) [3, 6] . Currently, however, very little information is available regarding the estrogenic activity of estuarine sediments. This is a considerable gap given that sediments may represent the final sink for many estrogenic substances that enter the aquatic environment.
In the environment, chemicals occur as complex mixtures arising from both anthropogenic and natural sources. The ER agonist potency of the compounds in these mixtures will differ widely and range over several orders of magnitude. Interactions between compounds with conflicting properties (e.g., antiestrogenic or androgenic) may also affect the overall estrogen potential of complex environmental mixtures. Targeted chemical analysis can be used to determine the concentration of selected estrogen compounds. However, the ER agonist potency of these compounds may not be very well characterized, and analytical methods may not be available to measure all the ER agonists present. Additionally, the identity of all the ER agonists in environmental complex mixtures is unknown, and determining the individual concentrations of compounds in complex mixtures does not account for interactions (e.g., additivity) and provides little or no information regarding their biological effect. An alternative approach is to use an in vitro cell bioassay to estimate the total receptor-mediated estrogenic activity of all the compounds in environmental complex mixtures [7] [8] [9] . Such a bioanalytical approach offers a rapid, sensitive, and relatively inexpensive solution to the limitations discussed above [10] .
The aim of the present study was to determine the in vitro estrogenic activity of compounds in sediments sampled from UK estuaries using the in vitro recombinant yeast screen (YES assay) and to identify the ER agonist present using a bioassaydirected, fractionation approach.
MATERIALS AND METHODS

Materials
Hexane, dichloromethane (DCM), acetone, methanol, water, and iso-propylalcohol were of glass-distilled grade and obtained from Rathburns (Walkerburn, UK). Silica solid-phase extraction (SPE) columns were obtained from IST (Hengoed, UK).
Sample collection
During the summer of the year 2000, sediment samples (0.5 or 10 L) were collected by van Veen grab (depth, 10 cm) from a small boat and stored in 0.5-L, solvent-rinsed glass jars or 10-L, stainless-steel containers. The sample stations were located along the rivers Mersey, Tees, Thames, and Tyne as well as Southampton Water (UK) ( Fig. 1 and Table 1 ). These represent some of the UK estuaries most impacted by pollution, with inputs from a broad range of activities (e.g., effluents containing domestic and industrial waste, refineries, shipping, and dry-dock operations).
During the summer of the year 2001, sediment cores (depth, 3 m) were collected from the Tyne estuary. Two samples were collected from the northern bank, one from the dredged channel, and two from the southern bank (Fig. 1 ). Samples were taken from the cores at 1-m intervals to give three samples per core. These samples were then transferred to 500-ml glass jars.
Sediment sample extraction
Sediments were extracted as described by Thomas et al. [11] . Briefly, a 2-L sediment sample was divided among Teflon tubes and centrifuged at 1,000 g for 30 min to separate the sediment pore water from the pelleted sediment. The pore water was drawn off and extracted using octylsilane (C8; Isolute; International Sorbent Technology, Hengoed, UK) SPE and eluted using methanol (twice with 5 ml each time) and DCM (2 ϫ 5 ml). The pelleted sediment was dried at room temperature to constant weight, ground, and passed through a 2-mm, stainless-steel sieve. Samples (ϳ10 g) were extracted with DCM (10 ml), mechanically shaken for 30 min, sonicated for 10 min, and centrifuged at 1,730 g for 10 min. This process was then repeated twice. The supernatant was removed and the extracts combined. The extracts were then concentrated to 5 ml using a TurboVap (30ЊC; Zymark, Hopkinton, MA, USA).
Assay for estrogenic activity
Samples were tested for estrogenic activity using the YES assay, which has been fully validated [12] and used in similar investigations [3, 6] . The bioassay detects estrogenic compounds that bind to the ER (e.g., E 2 , estrone, alkylphenols, and bisphenol A). The bioassay was carried out using the method of Routledge and Sumpter [12] and was described in detail by Thomas et al. [6] . An equivalent E 2 concentration in the extracts was estimated by comparing the response of each sample to that of an E 2 standard. All data are presented as ng E 2 L Ϫ1 .
Coarse normal-phase fractionation
Sediment extracts shown to induce a response in the YES assay were initially fractionated by normal-phase SPE using silica-glass SPE columns (IST). The DCM extracts were transferred into hexane and made up to 100 ml. Samples were then passed through the column, and the postcolumn hexane was collected. The column was then eluted with hexane (10 ml) that was added to the original postcolumn hexane. Next, the column was consecutively eluted with 10 ml of DCM, acetone, and methanol, and each individual fraction was reduced in volume to 5 ml for assay.
High-performance liquid chromatographic fractionation
All SPE extracts with a positive assay response were fractionated into fine fractions by high-performance liquid chromatography (HPLC). For acetone normal-phase SPE extracts and pore-water extracts, this was performed using an EconoPrep C18 semipreparative HPLC column (30 cm ϫ 10 mm ϫ 5 m; Phenomenex, Cheshire, UK) fitted with a guard column (5 cm ϫ 10 mm ϫ 5 m) at a flow rate of 5 ml min Ϫ1 with a ultraviolet detector (230 nm) using HPLC-grade methanol and water as a mobile phase. Gradient elution was used over 30 min. Typically, a linear, 25-min gradient of 40:60 methanol: water (v/v) to 100% methanol was used, ending with a 5-min, 100% methanol flush. Thirty 5-ml fine fractions were collected (one per minute). For DCM normal-phase SPE extracts, this was performed using a Phenosphere semipreparative HPLC column (25 cm ϫ 10 mm ϫ 10 m; Phenomenex) or a Partisil PAC semipreparative HPLC column (25 cm ϫ 10 mm ϫ 10 m; Phenomenex), both of which were fitted with a guard column (5 cm ϫ 10 mm ϫ 10 m; Phenomenex) at a flow rate of 5 ml min Ϫ1 using HPLC-grade hexane, DCM, and isopropylalcohol as a mobile phase. Gradient elution was used over 30 min, with the composition of the mobile phase being dependent on the toxicity profile observed following coarse fractionation. Typically, an isocratic, 10-min period of hexane was used, followed by a 15-min gradient of 100% hexane to 100% DCM and ending with a 100% iso-propylalcohol flush. Thirty 5-ml fine fractions were collected and stored at Ϫ20ЊC.
Fraction analysis
All HPLC fractions demonstrating a positive assay response were analyzed by gas chromatography-(electron-impact) mass spectrometry (GC-[EI]MS) using the method of Thomas et al. [11] . Samples were transferred into DCM, dried using anhydrous Na 2 SO 4 , and reduced in volume to 100 l before analysis using a Finnigan GCQ ion-trap mass spectrometer (Finnigan, Berman, Germany) operated in full-scan mode (50-500 AMU). Mass spectra of major peaks were compared to reference spectra in the National Institute of Standards and Technology (Gaithersburg, MD, USA) mass spectral database using the Automated Mass Spectral Deconvolution and Identification System (AMDIS National Institute of Standards and Technology, Gaithersburg, MD, USA) for tentative identification. The comparison of Kovat retention indices obtained from reference compounds was used to confirm identifications. Compounds suggested by AMDIS were also tested in the YES assay.
Quantitative structure-activity relationship model
In the case of ER agonist identification, when a reference compound was unavailable or numerous compounds were suggested by AMDIS, quantitative structure-activity relationship (QSAR) calculations were performed. These were based on a training set using rat ER-binding data and were performed as described by Mekenyan et al. [13] .
RESULTS AND DISCUSSION
Pore-water ER agonist potency
All the pore water samples collected from the Tyne, Tees, Humber, and Thames estuaries tested positive for ER agonists ( Table 1) . Three of five samples collected from Southampton Water tested positive, whereas none of the samples collected from the Mersey estuary did. Samples collected from the Tyne and Tees estuaries generally showed the highest ER agonist potencies (10-66 ng E 2 L Ϫ1 ), although the highest measured potency was in a sample collected from Hythe Marina on Southampton Water (68 ng E 2 L Ϫ1 ).
To our knowledge, these are the first reported data for the ER agonist activity of sediment pore waters. Of the 26 sediment pore waters examined for ER agonists, 18 tested positive. This suggests that hydrophilic in vitro ER agonists are present in the sediments collected for the present study.
Sediment extract ER agonist potency
All but four of the tested sediment extracts were positive for ER agonists ( Table 1 ). The negative samples were all collected from the Mersey estuary. The ER agonist potency of the samples that scored positive ranged from 0.2 to 13 g E 2 kg
Ϫ1 . The highest activity was detected in a sample collected at Dabholm Gut on the Tees estuary.
The ER agonist activity was detected in 25 of 28 samples tested using the YES assay, confirming the presence of rela- tively hydrophobic ER agonists in these samples. This is unsurprising, because many of the sites from which the samples were collected are heavily contaminated by inputs from both diffuse and point sources.
The ER agonist potency of sediment samples collected along the Dutch coast has been performed using the ER-mediated chemical-activated luciferase gene expression (ER-CA-LUX) assay (Biodetection Systems, Amsterdam, The Netherlands) [9] . These sediment extracts had ER agonist activities in a range similar to those determined for the present study (0.1-1.1 g E 2 kg Ϫ1 ).
Tyne sediment core ER agonist potency
The ER agonist potency of the Tyne sediment cores is presented in Figure 2 . The vertical profiles obtained for the samples collected from the northern bank of the estuary show a definite decrease in ER activity in the deeper samples (cores 1 and 2). In the sample taken from the dredged navigation channel (core 3), the ER activity is low, and little difference is found between the activity at different depths. The ER activity in the southern bank samples (cores 4 and 5) was similar with depth; however, the activity was higher than that determined for the navigation channel yet similar to that determined in the top 1 m of the northern bank sample.
The ER agonist potency of the Tyne core samples was generally comparable with those determined for the sediments collected from the Tyne in the year 2000 (Fig. 1) . These limited data suggest that significant variability occurs in the ER activity of sediments at different locations, both within the estuary and within a small area. The differences in activity measured in the vertical profiles from each location suggest that recently deposited material as well as material that is constantly disturbed contain high concentrations of ER agonists. The lower levels of activity observed in cores 1 and 2 from the northern bank suggest either that ER activity has been low historically or that the compounds responsible are being degraded with time. Further work is required to investigate this question.
Characterization of ER agonists in sediment pore waters
Samples from Tees British Steel, Tees Billingham, Tyne Team Confluence, and Hythe Marina were fine-fractionated on a reversed-phase HPLC column, yielding 30 fractions for each sample (Fig. 3 ). These fractions were tested using the YES assay. In the Tees British Steel sample, three clusters of estrogenic fractions were produced from fine-fractionation (fractions 4, 14, and 19-30). of these fractions failed to identify any candidate estrogens. Although none of the estrogenic activity in pore waters was characterized, it is possible, through use of the YES assay, to state that unknown ER agonists are present in pore waters collected from UK estuaries. The fractionation profiles obtained for each sample suggest that the same compound(s) in each sample may cause the major peak of ER activity. From the fractionation profiles, it could also be assumed that steroid estrogens are responsible for the ER agonist activity, because they elute at the same time as the unknown pore-water ER agonists. However, using GC-(EI)MS, it was not possible to detect steroid estrogens in the samples. This suggests that compounds of the same polarity (log K ow ϭ 3-4) are responsible for the measured activity. It may be that the compounds responsible are not suitable for analysis by gas chromatography (i.e., nonvolatile or thermally labile) or are highly active and only present at concentrations too low to be detected using our system.
Characterization of ER agonists in sediment solvent extracts
Sediment solvent extracts showing estrogenic activity that were collected from Tyne Howdon and Tees Dabholm Gut were chosen for bioassay-directed characterization. Coarse normal-phase fractionation of these extracts provided four further fractions for assay. When tested in the YES assay, the sediment extracts from Howdon sewage treatment works and Dabholm Gut produced two positive fractions (fractions 2 and 3). A series of both normal-and reversed-phase HPLC fractionations were carried out on the sediment solvent extracts from Howdon sewage treatment works. Figure 4 shows a graphical representation of the in vitro ER agonist potency of the fine fractions. Repeated fractionation was necessary to eliminate as many nonestrogenic interferences as possible to facilitate the GC-(EI)MS identification of candidate estrogens. Even after successive fractionations, the GC-(EI)MS total ion chromatograms were still very complex, containing 10 to 100 compounds. These lists of compounds were screened using an ER QSAR. Three compounds were identified as contributing toward the activity shown in the sediments: Nonylphenol (a breakdown product of nonylphenol ethoxylates, used as a surfactant in many industrial applications), cinnarizine (a synthetic antihistamine drug), and cholesta-4,6-dien-3-one (an oxidation product of cholesterol) ( Table 2 ). Cinnarizine and cholesta-4,6-dien-3-one would be more likely to originate from As compared to E 2 using the yeast estrogen screen assay (E
